US Archives - Page 66 of 100 - European Medical Journal

Pharmacy Closures Threaten Community Care Access

Independent pharmacies and those in predominantly Black and Latinx neighborhoods face a growing crisis as retail pharmacy closures surge, impacting access to care and community health.

Advances in Atopic Dermatitis and Chronic Hand Eczema

AD, also known as eczema, is a chronic condition characterized by inflammation, redness, and skin irritation, which can significantly…

AMJ Dermatology 1 [Supplement 1]

Discover the latest breakthroughs in dermatology from the 2024 Fall Clinical Dermatology Conference. This article reviews new findings on…

Thrombosis Risks Rise in ICI-Treated Lung Cancer

Emerging data highlights a critical complication for patients with metastatic lung cancer undergoing treatment with immune checkpoint inhibitors (ICIs), including PD-1 and PD-L1 blockers.

Vaccine Timing Boosts Cancer Survival Rates

Patients with cancer vaccinated against COVID-19 within 6 months before infection showed significantly higher survival rates, according to a new analysis from the ASCO COVID-19 Registry.

Interview: Roy Fleischmann

There are probably two main reasons. The first is that during medical school and my post-medical school training, the most dynamic…

Remdesivir Lowers 30-Day COVID-19 Readmissions in Vulnerable Patients

A retrospective study highlighted the effectiveness of remdesivir in reducing 30-day COVID-19-related readmissions among vulnerable patient populations, including older adults and those with immunocompromising conditions.

AI, Social Media, and Dermatology: A New Review

A newly published review sheds light on how the digital revolution is reshaping the field of cosmetic dermatology.

AMJ Neurology 1 [Supplement 1]

Explore our latest article summarising key discussions from a symposium at the 40th Congress of the European Committee for…

Ozanimod in Relapsing Multiple Sclerosis: New Insights

Ozanimod is a sphingosine 1-phosphate (S1P) receptor 1 and 5 (S1PR1 and S1PR5) modulator approved in multiple countries for the…